Barclay A Phillips's Net Worth
$28.4 Million
Who is Barclay A Phillips?
Barclay A Phillips has an estimated net worth of $28.4 Million. This is based on reported shares across multiple companies, which include IMMUNIC, INC., NOVAVAX INC, G1 Therapeutics, Inc., ACORDA THERAPEUTICS INC, and MICROMET, INC..
SEC CIK
Barclay A Phillips's CIK is 0001265801
Past Insider Trading and Trends
2006 was Barclay A Phillips's most active year for acquiring shares with 13 total transactions. Barclay A Phillips's most active month to acquire stocks was the month of October. 2008 was Barclay A Phillips's most active year for disposing of shares, totalling 24 transactions. Barclay A Phillips's most active month to dispose stocks was the month of May. 2018 saw Barclay A Phillips paying a total of $97,300.00 for 5,000 shares, this is the most they've acquired in one year. In 2008 Barclay A Phillips cashed out on 569,106 shares for a total of $7,120,079.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNIC, INC. (IMUX) Snapshot price: $1.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVAVAX INC (NVAX) Snapshot price: $3.79
SVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.62% | 2.06K |
$0.89 | $1,830.73 | 38.67K |
Jul 31
| |||
Form 4
| +215.29% | 25K |
$0.84 | $20,950.00 | 36.61K |
May 11
| |||
Form 4
| +16.36% | 1.63K |
$1.12 | $1,828.96 | 11.61K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
| +4.42% | 422 |
$4.29 | $1,810.38 | 9.98K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +4.43% | 405 |
$4.38 | $1,773.90 | 9.56K |
Jan 31
| |||
Form 4
| -75.79% | -28.66K |
$13.06 | -$374,323.37 | 9.15K |
Aug 19 - Aug 20
| |||
Form 4
| +2.06% | 764 |
$2.28 | $1,741.92 | 37.81K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +29.27% | 8.39K |
$2.28 | $19,124.64 | 37.04K |
Jan 31
| |||
Form 4
| +21.14% | 5K |
$4.11 | $20,549.50 | 28.66K |
Oct 3
| |||
Form 4
| +59.11% | 8.79K |
$2.28 | $20,036.64 | 23.66K |
Jul 31
| |||
Form 4/A
| +50.67% | 5K |
$4.25 | $21,225.00 | 14.87K |
Mar 25
| |||
Form 4
| -25.17% | -5.00K |
$4.25 | -$21,225.00 | 14.87K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
∞
| 9.87K |
$2.29 | $22,597.72 | 9.87K |
Jan 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +33.33% | 50K |
$1.90 | $95,000.00 | 200K |
Jun 12
| |||
| No matching records found | |||||||||
G1 Therapeutics, Inc. (GTHX) Snapshot price: $4.79
SVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$29.69 | -$102,291.00 |
0
|
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACORDA THERAPEUTICS INC (ACOR) Snapshot price: $17.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.43% | -235.00K |
$30.55 | -$7,120,079.02 | 974.74K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
∞
| 543.8K |
—
|
—
| 543.8K |
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MICROMET, INC. No price found
SVP, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -100.00% | -1.48K |
$11.00 | -$16,313.00 |
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| -100.00% | -334.11K |
$4.32 | -$124,705.00 |
0
|
Aug 29 - Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 1.01M |
$12.00 |
—
| 1.01M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||